Get started

Stockstotrade

$OLB Announces Plan to Offer Cryptocurrency Payment OptionsOLB Group Announces Plan to Offer Cryptocurrency Payment Options via Blockchain Technology on its OMNICOMMERCE Platform and SecurePay TM Gateway OLB’s SecurePay TM Payment Gateway to Enable Merchants to Seamlessly Offer Cryptocurrency Payments $OLB upgraded its SecurePay payment gateway system to support Cryptocurrencies including Bitcoin, Ethereum, USDC and DAI across all merchant platforms. SercurePay is compatible with mobile, tablet-based and cloud infrastructure and will be integrated into the merchants current payment ecosystem, in order to enable the acceptance of Cryptocurrency payments. finance.yahoo.com
NASDAQ:OLB
by AlenCiken
$AUVI Announces Acquisition of the Airocide Technology PlatformApplied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction Developed with NASA as a patented pathogen killing technology Proprietary photocatalytic oxidation process thoroughly destroys viruses, bacteria, spores, and fungi as well as other carbon-based molecules Airocide® air disinfection technology compliments and expands the SteriLumen platform, together providing a more comprehensive solution for air and surface Accelerates the strategy to grow revenues through complimentary acquisitions Enhances scale in the fast-growing disinfection device market Akida's revenue for the full calendar year 2020 is estimated to be $4.7 million with EBITDA of approximately $921,000. Airocide technology is widely accepted and currently used by nationally recognized brands such as Hard Rock Café, the US Army, Stag's Leap vineyards and many more. finance.yahoo.com
A
by AlenCiken
Closing of an Upsized $20.7 Million Underwritten Public OfferingInspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering $NSPR today announced the pricing of an upsized underwritten public offering of securities for gross proceeds of $18 million (or $20.7 million if the underwriters exercise their option to purchase additional securities) prior to deducting underwriting discounts and estimated offering expenses payable by InspireMD. The offering is comprised of 29,032,258 Units, priced at a public offering price of $0.62 per Unit, with each Unit consisting of one share of Common Stock and one Series G Warrant to purchase one-half of one share of Common Stock, at an exercise price of $0.682 per share and expiring on the fifth anniversary of the date of issuance. finance.yahoo.com InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option $NSPR today announced the closing of an upsized underwritten public offering of units for gross proceeds of approximately $20.7 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses payable by InspireMD. finance.yahoo.com
N
by AlenCiken
$JG Partners with Kuaishou to Improve Monetization EfficiencyAurora Mobile $JG Partners with Kuaishou to Improve Monetization Efficiency $JG today announced that it has entered into a partnership agreement with Kuaishou Technology (01024.HK) (“Kuaishou”), China’s leading short video content community and social platform, to improve advertising monetization efficiency. By leveraging its powerful artificial intelligence (“AI”) and advanced analysis technologies, Aurora Mobile's advertisement SaaS services will enable Kuaishou to help brands and performance-based advertisers to accurately target potential customers, enhance advertising conversion rate, reduce operational costs, and promote a mutually beneficial relationship between Kuaishou and advertisers on its platform. The short-form video market continues to experience huge growth. Short-form video advertising that features high traffic and conversion rates has become a preferred marketing approach for many brands and performance-based advertisers. According to the cooperation agreement, Aurora Mobile will benefit from a revenue share agreement based on advertising revenues allocated to Kuaishou if the labels provided by Aurora Mobile are used by advertisers on the platform. finance.yahoo.com
NASDAQ:JG
by AlenCiken
$ZOM could surge 100% due to upcoming launch of TruformaTangible catalyst behind surge is due to the upcoming launch of Truforma , Zomedica’s point-of-care (POC) diagnostic device for the detection of thyroid disease in dogs and cats and adrenal disease in dogs. The platform will hit the market on March 30 , and ahead of the product’s debut, the company has also just nabbed a vital distribution deal. Last week, Zomedica announced an agreement with Miller Veterinary Supply who will distribute Truforma. Miller is the U.S.’s oldest wholesale veterinary distributor and one of the veterinary industry’s fastest growing businesses. The company will be Zomedica’s representative in the eastern and mid-eastern states. Its sales and customer service efforts will be bolstered by sales representatives assigned by Zomedica, which the company is currently recruiting as it prepares for the launch. The pet market has been a prime beneficiary of the pandemic’s stay-at-home mandates and according to the American Pet Products Association, spending in the segment reached a record $99 billion in the U.S. last year. Outlay on diagnostic care in this market is expected to grow to $2.8 billion in 2024 from $1.7 billion in 2019. H.C. Wainwright analyst Swayampakula Ramakanth says that ahead of Truforma’s debut, the agreement “strengthens the commercial machinery.” “We are encouraged by the progress in commercial preparation for the upcoming launch, and accordingly we are raising the probability of launch to 90%, up from 75% previously,” the 5-star analyst said. “Additionally, due to the lower yield of the long-term Treasury note that has resulted in a lower risk-free rate and a lower market risk premium, we have adjusted the discount rate to 6% from 12%.” To this end, Ramakanth boosted his price target on ZOM from $0.3 to $1.2, suggesting upside of an additional 20% from current levels. Needless to say, Ramakanth’s rating stays a Buy. finance.yahoo.com
AMEX:ZOM
by AlenCiken
$AREC Announces Filing of SPAC Registration Statement$AREC American Resources Corporation Announces Filing of SPAC Registration Statement $AREC Company's SPAC is targeting acquisitions in the land holding and resource industry, and will focus on advancing land and resource assets towards a modern-day business model of clean energy, recycling and redevelopment, and social impact. $AREC today announced that American Acquisition Opportunity Inc., a special purpose acquisition company (the "SPAC" or "AAOI"), in which the Company has an indirect investment, filed a Registration Statement on Form S-1 (the "Registration Statement") with the Securities and Exchange Commission ("SEC") on February 4, 2021 in connection with a proposed initial public offering of its units. The proposed public offering is expected to have a base offering size of $100 million, or up to $115 million if the underwriters' over-allotment option is exercised in full. finance.yahoo.com
NASDAQ:AREC
by AlenCiken
3
Sabra Capital Partners places a $7 target on SupercomSeeking alpha: Sabra Capital Partners places a $7 target on Supercom. Explosive Potential, Limited Downside: We view the base level value of the Company to be $7.00 per share based on a multi-year estimate that revenues will rebound back to $35mm. High conviction. While none of its coronavirus tracking pilots have materialized into a formal, large scale contract, news is gaining momentum in the Company’s backyard, Israel. seekingalpha.com
NASDAQ:SPCB
by AlenCiken
2
Why ATA Creativity Skyrocketed 951% yesterdayWhy ATA Creativity Skyrocketed 951% yesterday There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. ATA shares were buoyed — thanks to discussions stock trading groups on Facebook, Discord chat rooms, the r/Daytrading subreddit, Twitter hashtags, and YouTube channels before the market opened. Many of these posts mentioned the advantages of the high volume and relatively low float (31.74M) of the stock. ATA Creativity is not on the list of most talked about stocks on r/WallStreetBets, as compiled by Swaggystocks.
NASDAQ:AACG
by AlenCiken
Why LAIX Stock Price Increased Over 100% in Pre-MarketWhy LAIX Stock Price Increased Over 100% in Pre-Market LAIX is an AI company that provides online English learning products and services in China. Since the company has not announced any news directly and there are no SEC reports to trigger a stock price increase, it appears there was a coordinated move on social media to drive the price up, similar to the reason why ATA Creativity Global went up more than 936% yesterday. I am seeing references to LAIX in stock trading groups on Facebook, Discord chat rooms, stock trading subreddits, Twitter hashtags, and YouTube channels before the market open. Many of these posts mentioned the advantages of the high volume and relatively low float of the stock. I noticed a user on StockTwits point out that the short percentage yesterday was 85% and there were no available shares to short on WeBull. “If you’re short on this ticker may I suggest you cover now before it gets out of control,” warned the user. Since the business model appears to be similar to ATA Creativity Global, it also appears that there is a sympathy play in effect as well. And since the company shares have a relatively small float and there is a high squeeze probability, day traders are also jumping on LAIX. pulse2.com
L
by AlenCiken
REE Automotive to List on NASDAQ Through Merger with $VCVCREE Automotive to List on NASDAQ Through Merger with 10X Capital Venture Acquisition Corp REE’s fully-flat and modular EV platforms are based on proprietary REEcorner technology, positioned to become the cornerstone of next-generation e-Mobility. The transaction is expected to provide more than $500 million of gross proceeds to the Company. This includes funds from a fully committed $300 million PIPE with participation from long-term strategic investors including Koch Strategic Platforms, Mahindra & Mahindra and Magna International. As a result of outsized demand, the PIPE offering was meaningfully oversubscribed and upsized. Pro forma equity value of the merger is approximately $3.6 billion and pro forma enterprise value of $3.1 billion, at the $10.00 per share PIPE price and assuming minimal 10X SPAC shareholder redemptions. targeting a $700 billion total addressable market REE has an orderbook comprised of signed indications of interest for over 250,000 platforms, representing 27% of their total cumulative expected revenue of $19.1 billion by 2026. The transaction will accelerate mass production of REEcorner technology and modular EV platforms, expected to begin in 2023. The proposed transaction expected to be completed by the end of the first half of 2021. www.businesswire.com
V
by AlenCiken
2
“Strong Buy” Penny Stock With Over 200% Upside on the Horizon“Strong Buy” Penny Stock With Over 200% Upside on the Horizon a biotechnology company with a focus on the treatment of glioblastomas, a class of aggressive tumors that attack the braid and spinal cord. These cancers, while rare, are almost always terminal, and CNS is working a new therapy designed to more effectively cross the blood-brain barrier to attack glioblastoma. Berubicin, CNS’s flagship drug candidate, is an anthracycline, a potent class of chemotherapy drugs derived from the Streptomyces bacteria strains, and used in the treatment of a wide variety of cancers. Berubicin is the first drug in this class to show promise against glioblastoma cancers. The drug candidate has completed its Phase 1 clinical trial, in which 44% of patients showed a clinical response. This number included one patient who showed a ‘Durable Complete Response,’ defined as a demonstrated lack of detectable cancer. Following the success of the Phase 1 study, CNS applied for, and received, FDA approval of its Investigational New Drug application. This gives the company the go-ahead to conduct a Phase 2 study on adult patients, an important next step in the development of the drug. CNS plans to start the mid-stage trial in 1Q21. Based on the potential of the company’s asset in glioblastoma, and with its share price at $2.22, several analysts believe that now is the time to buy. Among the bulls is Brookline’s 5-star analyst Kumaraguru Raja who takes a bullish stance on CNSP shares. Berubicin is the first anthracycline to cross the blood-brain barrier in adults and access brain tumors… Berubicin has promising clinical data in a Phase 1 trial in recurrent glioblastoma (rGBM) and has Orphan drug designation for treatment of malignant gliomas from the FDA. We model approval of Berubicin for treatment of recurrent glioblastoma in 2025 based on the Phase 2 data with 55% probability of success for approval. We model peak sales of $533 million in 2032,” Raja opined. “CNS pipeline also includes WP1244 (novel DNA binding agent) that is 500x more potent than daunorubicin in inhibiting tumor cell proliferation is expected to enter the clinic in 2021… In vivo testing in orthotopic models of brain cancer showed high uptake of WP1244 by brain and subsequent antitumor activity,” the analyst added. finance.yahoo.com
NASDAQ:CNSP
by AlenCiken
2
Why $NAKD Stock crashed Down Sharply from last week?Why $NAKD Stock crashed Down Sharply from last week? The WallStreetBets short squeeze continued to unravel this week with investors pocketing gains and latecomers hoping for a second bounce. A number of factors are driving the ongoing sell-off as $NAKDe stock peaked last week. The first is that many short-sellers closed out their bets as the stocks soared last week, riding a massive short squeeze and gamma squeeze. Second, savvy traders who rode the stocks up sold it to take profits. Third, fundamentals matter, and stocks will naturally revert to their mean barring any significant change in fundamentals. After all, a stock is a part-ownership in a business, not a lottery ticket. So the possibility of a short squeeze is diminished, and the "easy money" has come and gone. Traders who now buy any of these three stocks are banking on another pump-and-dump rally to lift them. Investors should also be aware that $NAKD stock is still significantly above historical trading level and fundamentals are weak, meaning stock could fall significantly further. www.fool.com
N
by AlenCiken
7
New Executive Leadership to Drive Bitcoin Mining OperationsSino-Global Announces New Executive Leadership to Drive Bitcoin Mining Operations Expansion announced today that the newly appointed Chief Operating Officer Mr. Lei Nie and Chief Technology Officer Mr. Xintang You will spearhead the Company's effort to enter Bitcoin mining. As Sino-Global evaluates its strategy for 2021 and beyond, the planned Bitcoin mining expansion follows a series of steps in preparation. The plan utilizes leadership team members who specialize in information technology, Blockchain, cryptocurrency mining operations and more. Given the Company's plan to enhance the traditional logistics service platform through leveraging innovative technologies, the Company is excited to explore opportunities created by current market conditions and enter the cryptocurrency sector. finance.yahoo.com
S
by AlenCiken
LIZHI INC. Issues Letter to ShareholdersLIZHI INC. Issues Letter to Shareholders Tiya, our audio-based social product, soared to rank among the top 4 social networking apps in the U.S. Within a few months of Tiya’s launch worldwide, it has been ranked among the top 10 social networking apps in about 50 countries worldwide. Currently, Tiya has users in over 200 countries. We believe that online social networking through audio will become a dominant method of social networking in the future. we further developed LIZHI’s corporate value, while elevating our talent training initiatives, including forming collaborations with universities to cultivate talents specializing in AI technology. Moreover, we launched an "Innovation Training Camp" internally to equip our employees with innovative thinking in tandem with scientific methods. We also continued to invest in our management team with a lot of resources and systematic training to enhance management skills. we launched a new mobile app, LIZHI Podcast (also named LIZHI BOKE in Chinese), in January 2021, to provide our users with a more compelling podcast experience.
L
by AlenCiken
3 potential stocks to expand your portfolioThinking about which financial instrument to add to your portfolio is always a challenging task, especially in a market where almost everything is overbought. You may already own these three stocks, but if you don't they have good technicals and fundamentals to get in or to add up. Starting first with the Ferrari. At first, sounds like an exotic stock, but the race-car manufacturer is still on track. And it's not because of the newly born millionaires from the latest rise in the price of Bitcoin ... Let's take a look at what's under the "hood" of Ferrari. Technically we have a well-formed uptrend and Yesterday that trend was tested at the earnings which were good. Volumes activity was big since the bottom formed after the first lockdown. The candle formation ended with a pinbar . MACD and RSI are still lagging, but the trend holds. Fundamentally the financial look of the company is stable in revenue and EPS aspect. Also, the racing car manufacturer is decided to take on the electric cars market, as well as delivering three new models. Next is Nio. Already a familiar company and attracting more and more investors. Earnings are on the 9th of March. Revenues and EPS are shaky, but investors are betting on the long-term success of the company. Ford terminated their contract to manufacture electric cars in China, but Nio managed to cement their position in the Asian country. MACD here is lagging, but RSI is moving above 50 and the trend is intact. The price is currently forming a bullish flag on the daily chart and if it is triggered we may head towards the $70 range. Last, but not least - Raytheon . Technicals are looking better here as RSI is moving from oversold territory and above 50. MACD has a crossing and the histogram is starting to move into positive territory. The uptrend is intact. Earnings passed, although they are a bit disappointing, financials are looking stable for the company. The company recently won a $290 million contract with the U.S. Navy. That will attract more revenue for the company and will keep it busy in the long-term.
NYSE:RACELong
by DailyChartist
Purchase Order for HybridTech Armor© Panels for Aircraft CarrierCPS Technologies Corporation receives Purchase Order for HybridTech Armor© Panels for Aircraft Carrier CPSH today announced receipt of a purchase order for HybridTech Armor© Panels to be installed as the strike face of advanced ballistic shields to support U.S. Navy CVN class ships. The purchase order covers panels to equip all crew-served weapons stations on one aircraft carrier. We have received a $28.7 million IDIQ contract from the Navy to address the aircraft carrier fleet, with an initial delivery order for the first aircraft carrier.” finance.yahoo.com
NASDAQ:CPSH
by AlenCiken
1
Acquires Exclusive Rights to Rare Earth Element InnovationsAmerican Resources Corporation Acquires Exclusive Rights to Purdue University's Rare Earth Element Innovations, Critical for Clean Energy Technologies. An environmentally safer method of rare earth and other critical material separation and purification using ligand-assisted chromatography for coal, coal byproducts, recycled permanent magnets and Lithium Ion batteries. Announced that, with the addition of Hasler Ventures LLC, the Company has licensed ligand assisted displacement ("LAD") chromatography patents and knowhow to further expanded its capability in environmentally friendly separation and purification of rare earth elements. These exclusive patents and technologies, developed at Purdue University, are specific to the processing of separated and pure rare earth metals and critical elements from coal byproducts, recycled permanent magnets and lithium-ion batteries. Rare earth elements (REEs) include the 15 elements in the lanthanide series plus scandium (Sc) and yttrium (Y). They are essential ingredients for magnets, metal alloys, polishing powders, catalysts, ceramics, and phosphors, which are important for high-technology and clean energy applications. The global REE market is estimated at approximately $4 billion dollars and growing at 8% per year. finance.yahoo.com
NASDAQ:AREC
by AlenCiken
2
Space launch company Astra to go public via merger with SPAC HOLastra-to-become-the-first-publicly-traded-space-launch-company-on-nasdaq-via-merger-with-holicity BlackRock-managed funds and accounts lead investment in Astra to launch a new generation of space services to improve life on Earth. The transaction reflects an implied pro-forma enterprise value for Astra of approximately $2.1 billion. Upon closing, the transaction is expected to provide up to $500 million in cash proceeds, including up to $300 million of cash held in the trust account of Holicity and an upsized $200 million PIPE led by funds and accounts managed by BlackRock. In December 2020, Astra joined a small, elite group of companies that have made it to space. With over 50 launches in manifest across more than 10 private and public customers, including NASA and DOD, Astra has booked over $150 million of contracted launch revenue. Astra will begin delivering customer payloads this summer and begin monthly launches by the end of this year. The proposed transaction, which is expected to be completed in the second quarter of 2021. astra.com
H
by AlenCiken
ANVS401 Improves Cognitive and Functional Outcomes in StrokeAnnovis Bio's Lead Candidate ANVS401 Improves Cognitive and Functional Outcomes in Stroke Mice Study data showing that a combination treatment using the Company's lead candidate ANVS401 and pifithrin after stroke improved mice locomotor activity and cognitive function more so than treatment with just one or the other agent. While both treatments yielded improvements in locomotor and cognitive function, the combined ANVS401/PFT- treatment proved able to enhance stroke-induced endogenous neurogenesis and improve the functional recovery in stroke animals. The combined treatment also significantly improved cognitive function more than the single treatment with PFT- alone. finance.yahoo.com
A
by AlenCiken